Axsome Therapeutics, Inc. (AXSM) compared with its closest peers (TGTX, OPK, INSM, RARE, CPRX). Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
TG Therapeutics, OPKO Health, Insmed, Ultragenyx Pharmaceutical, Catalyst Pharmaceuticals, Supernus Pharmaceuticals, Amphastar Pharmaceuticals, Organogenesis, Pacira BioSciences and Emergent BioSolutions share Axsome Therapeutics's sub-industry, pharmaceutical makers.
| Company | Market Cap | P/E |
|---|---|---|
| TG Therapeutics, Inc. (TGTX) | $8.31B | 18.7 |
| OPKO Health, Inc. (OPK) | $1.10B | -4.2 |
| Insmed Incorporated (INSM) | $27.47B | -27.1 |
| Ultragenyx Pharmaceutical Inc. (RARE) | $2.59B | -3.9 |
| Catalyst Pharmaceuticals, Inc. (CPRX) | $3.85B | 17.1 |
| Supernus Pharmaceuticals, Inc. (SUPN) | $2.66B | -73.0 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | $952.41M | 15.7 |
| Organogenesis Holdings Inc. (ORGO) | $231.61M | 34.5 |
| Pacira BioSciences, Inc. (PCRX) | $982.99M | 67.2 |
| Emergent BioSolutions Inc. (EBS) | $262.37M | 2.3 |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
AXSM overview · AXSM earnings · AXSM financials · AXSM KPIs · AXSM documents · AXSM ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.